- Home
- VRTX vs SHW Comparison
VRTX vs SHW Comparison
Compare VRTX & SHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRTX
- SHW
- Stock Information
- Founded
- VRTX 1989
- SHW 1866
- Country
- VRTX United States
- SHW United States
- Employees
- VRTX N/A
- SHW N/A
- Industry
- VRTX EDP Services
- SHW RETAIL: Building Materials
- Sector
- VRTX Technology
- SHW Consumer Discretionary
- Exchange
- VRTX Nasdaq
- SHW Nasdaq
- Market Cap
- VRTX 119.6B
- SHW 98.0B
- IPO Year
- VRTX 1991
- SHW N/A
- Fundamental
- Price
- VRTX $396.64
- SHW $342.52
- Analyst Decision
- VRTX Buy
- SHW Buy
- Analyst Count
- VRTX 30
- SHW 21
- Target Price
- VRTX $519.12
- SHW $395.29
- AVG Volume (30 Days)
- VRTX 1.5M
- SHW 1.7M
- Earning Date
- VRTX 02-03-2025
- SHW 01-23-2025
- Dividend Yield
- VRTX N/A
- SHW 0.83%
- EPS Growth
- VRTX N/A
- SHW 7.52
- EPS
- VRTX N/A
- SHW 10.03
- Revenue
- VRTX $10,625,800,000.00
- SHW $23,053,500,000.00
- Revenue This Year
- VRTX $12.54
- SHW $1.35
- Revenue Next Year
- VRTX $8.52
- SHW $4.38
- P/E Ratio
- VRTX N/A
- SHW $34.18
- Revenue Growth
- VRTX 10.06
- SHW 0.10
- 52 Week Low
- VRTX $378.00
- SHW $282.09
- 52 Week High
- VRTX $519.88
- SHW $400.42
- Technical
- Relative Strength Index (RSI)
- VRTX 23.70
- SHW 23.37
- Support Level
- VRTX $459.79
- SHW $362.45
- Resistance Level
- VRTX $474.19
- SHW $368.58
- Average True Range (ATR)
- VRTX 12.03
- SHW 6.66
- MACD
- VRTX -4.30
- SHW -4.69
- Stochastic Oscillator
- VRTX 18.93
- SHW 0.60
About VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
About SHW Sherwin-Williams Company (The)
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.